Dopamine: Functions, Signaling, and Association with Neurological Diseases

Autor(es)

Klein, Marianne O. ^[1] ; Battagello, Daniella S. ^[1] ; Cardoso, Ariel R. ^[1] ; Hauser, David N. ^[2] ; Bittencourt, Jackson C. ^{[1, 3]} ; Correa, Ricardo G. ^[2]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Lab Chem Neuroanat, BR-05508000 Sao Paulo - Brazil

^[2] SBP Med Discovery Inst, Ctr Translat Neurosci, 10901 North Torrey Pines Rd, La Jolla, CA 92037 - USA

^[3] Univ Sao Paulo, Inst Psychol, Ctr Neurosci & Behav, Sao Paulo - Brazil

• Tipo de documento: Artigo de Revisão
• Fonte: Cellular and Molecular Neurobiology; v. 39, n. 1, p. 31-59, JAN 2019.
• Citações Web of Science: 18

Resumo

The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided. (AU)

• Processo FAPESP: 16/02224-1 - A existência da neurogênese durante o período da lactação
• Beneficiário: Jackson Cioni Bittencourt
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 17/18019-0 - Investigação do papel regulador do hormônio concentrador de melanina (MCH) na lactação de ratas Long-Evans: efeitos da inibição do gene Pmch através da técnica de iRNA
• Beneficiário: Ariel Rodrigues Cardoso
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 17/17998-5 - Avaliação dos efeitos da administração crônica do hormônio concentrador de melanina (MCH) em ratas Long-Evans lactantes
• Beneficiário: Marianne Orlandini Klein
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado